Christopher Mina, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 11913 47th Dr Ne, Marysville, WA 98271 Phone: 913-568-3213 |
News Archive
Linagliptin is an effective and well-tolerated therapy for the long-term management of Type 2 diabetes, say the authors of an open-label extension study published in the International Journal of Clinical Practice.
A team of University of Pittsburgh mathematicians is using computational models to better understand how the structure of neural variability relates to such functions as short-term memory and decision making. In a paper published online April 2 in Proceedings of the National Academy of Sciences (PNAS), the Pitt team examines how fluctuations in brain activity can impact the dynamics of cognitive tasks.
S*BIO Pte Ltd today announced that a fourth novel, potential best-in-class compound discovered and developed by S*BIO has entered a Phase 1 clinical trial. The initiation of the study for S*BIO's oral multi-kinase inhibitor, SB1317 or TG02, in patients with advanced/refractory hematologic malignancies has triggered a payment from S*BIO's development and commercialization partner for the program, Tragara Pharmaceuticals.
Eating disorders may be overlooked in some groups - boys and some ethnicities - by physicians accustomed to diagnosing the condition in white teenage girls, say researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.
› Verified 5 days ago